Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats

Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.

Feb 8, 2026 - 14:00
 0  14
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow